Featured
Read our handpicked blogs, curated for you.
|
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If…
|
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the…
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
Recent releases
|
Adherence = Revenue: The Data Case Pharma CMOs Can’t Afford to Miss
Why Adherence is the Real Growth Lever: Let’s call it straight. For all the money pharma spends on marketing, the biggest gap isn’t awareness. It’s adherence. Doctors prescribe. Patients start. But…
|
Doctors Aren’t Ignoring You. They’re Ignoring Irrelevance
The Myth of Doctor DisengagementPharma marketers often complain that doctors are ignoring them. That reps can’t get meetings. That emails go unopened. That webinars feel like empty rooms. The truth…
|
Why CRMs Fail Pharma, and How Tech-Led Marketing Reclaims ROI
The Broken Promise of CRM in Pharma MarketingFor years, CRM in pharma marketing was sold as the silver bullet. Buy the system, train the reps, and suddenly you’d have airtight engagement with doctors…
|
Why Your Omnichannel Marketing Is Just Noise, And How to Fix It
We analyzed 20 pharma websites and spoke with 10 CMOs and digital leads from mid-to-large pharma brands across India. Almost everyone said the same thing. "We're spending on omnichannel HCP…
